RLMD logo

Relmada Therapeutics (RLMD) Working Capital

Annual Working Capital

$85.31 M
-$55.09 M-39.24%

December 31, 2023


Summary


Performance

RLMD Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRLMDbalance sheetmetrics:

Quarterly Working Capital

$47.62 M
-$13.82 M-22.50%

September 30, 2024


Summary


Performance

RLMD Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRLMDbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

RLMD Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-39.2%-33.9%
3 y3 years-19.1%-34.5%
5 y5 years+1056.3%+726.5%

RLMD Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-59.0%at low-77.4%at low
5 y5-year-59.0%at low-77.4%+726.5%
alltimeall time-59.0%+2794.1%-77.4%+330.6%

Relmada Therapeutics Working Capital History

DateAnnualQuarterly
Sep 2024
-
$47.62 M(-22.5%)
Jun 2024
-
$61.44 M(-14.7%)
Mar 2024
-
$72.00 M(-15.6%)
Dec 2023
$85.31 M(-39.2%)
$85.31 M(-15.3%)
Sep 2023
-
$100.68 M(-9.5%)
Jun 2023
-
$111.30 M(-11.3%)
Mar 2023
-
$125.43 M(-10.7%)
Dec 2022
$140.40 M(-32.6%)
$140.40 M(-15.6%)
Sep 2022
-
$166.33 M(-15.5%)
Jun 2022
-
$196.82 M(-6.4%)
Mar 2022
-
$210.37 M(+1.0%)
Dec 2021
$208.24 M(+97.4%)
$208.24 M(+186.7%)
Sep 2021
-
$72.64 M(-24.9%)
Jun 2021
-
$96.78 M(+6.3%)
Mar 2021
-
$91.06 M(-13.7%)
Dec 2020
$105.47 M(-8.7%)
$105.47 M(-13.6%)
Sep 2020
-
$122.08 M(-7.6%)
Jun 2020
-
$132.08 M(+16.9%)
Mar 2020
-
$112.98 M(+1861.0%)
Dec 2019
$115.48 M(+1465.2%)
-
Sep 2019
-
$5.76 M(-21.9%)
Jun 2019
$7.38 M
$7.38 M(+3579.8%)
Mar 2019
-
$200.50 K(-82.8%)
Dec 2018
-
$1.17 M(-120.0%)
DateAnnualQuarterly
Sep 2018
-
-$5.83 M(+84.2%)
Jun 2018
-$3.17 M(-388.3%)
-$3.17 M(+200.3%)
Mar 2018
-
-$1.05 M(-163.3%)
Dec 2017
-
$1.67 M(-7.1%)
Sep 2017
-
$1.80 M(+63.4%)
Jun 2017
$1.10 M(-82.4%)
$1.10 M(-45.5%)
Mar 2017
-
$2.01 M(-48.1%)
Dec 2016
-
$3.88 M(-18.4%)
Sep 2016
-
$4.76 M(-23.7%)
Jun 2016
$6.24 M(-25.6%)
$6.24 M(-33.4%)
Mar 2016
-
$9.37 M(-13.8%)
Dec 2015
-
$10.87 M(-18.9%)
Sep 2015
-
$13.40 M(+59.8%)
Jun 2015
$8.39 M(-913.4%)
$8.39 M(+227.7%)
Mar 2015
-
$2.56 M(-45.1%)
Dec 2014
-
$4.66 M(-122.6%)
Sep 2014
-
-$20.65 M(>+9900.0%)
Jun 2014
-$1.03 M(+6682.2%)
-
Feb 2014
-
-$32.40 K(+10.2%)
Nov 2013
-
-$29.40 K(+93.4%)
Aug 2013
-$15.20 K(-233.3%)
-$15.20 K(-33.9%)
May 2013
-
-$23.00 K(+1177.8%)
Feb 2013
-
-$1800.00(-115.8%)
Aug 2012
$11.40 K
$11.40 K

FAQ

  • What is Relmada Therapeutics annual working capital?
  • What is the all time high annual working capital for Relmada Therapeutics?
  • What is Relmada Therapeutics annual working capital year-on-year change?
  • What is Relmada Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Relmada Therapeutics?
  • What is Relmada Therapeutics quarterly working capital year-on-year change?

What is Relmada Therapeutics annual working capital?

The current annual working capital of RLMD is $85.31 M

What is the all time high annual working capital for Relmada Therapeutics?

Relmada Therapeutics all-time high annual working capital is $208.24 M

What is Relmada Therapeutics annual working capital year-on-year change?

Over the past year, RLMD annual working capital has changed by -$55.09 M (-39.24%)

What is Relmada Therapeutics quarterly working capital?

The current quarterly working capital of RLMD is $47.62 M

What is the all time high quarterly working capital for Relmada Therapeutics?

Relmada Therapeutics all-time high quarterly working capital is $210.37 M

What is Relmada Therapeutics quarterly working capital year-on-year change?

Over the past year, RLMD quarterly working capital has changed by -$24.39 M (-33.87%)